A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Karanicolas
Paul.Karanicolas@sunnybrook.ca
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hamilton Health Science Centre
Hamilton, Ontario, Canada
- London Health Science Centre
London, Ontario, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Sunnybrook Health Science Centre
Toronto, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2023
- Primary completion
- 28 Feb 2027
- Completion
- 1 Feb 2031
- Last update posted
- 23 Feb 2026
- Registered enrollment
- 115
- Registry id
- NCT05677113
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.